Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    AnaptysBio Inc.

    NASDAQ: ANAB · Real-Time Price · USD
    22.27
    0.07 (0.32%)
    At close: Jul 01, 2025, 10:39 AM

    AnaptysBio Statistics

    Share Statistics

    AnaptysBio has 29.38M shares outstanding. The number of shares has increased by -2.71% in one year.

    Shares Outstanding

    n/a
    		 29.38M

    Shares Change (YoY)

    n/a
    		 -2.71%

    Shares Change (QoQ)

    n/a
    		 -4.19%

    Owned by Institutions (%)

    n/a
    		 99.99%

    Shares Floating

    n/a
    		 26.44M

    Failed to Deliver (FTD) Shares

    n/a
    		 2,149

    FTD / Avg. Volume

    n/a
    		 0.32%

    Short Selling Information

    The latest short interest is 9.15M, so 31.16% of the outstanding shares have been sold short.

    Short Interest

    n/a
    		 9.15M

    Short % of Shares Out

    n/a
    		 31.16%

    Short % of Float

    n/a
    		 56.23%

    Short Ratio (days to cover)

    n/a
    		 10.39

    Valuation Ratios

    The PE ratio is -2.59 and the forward PE ratio is -4.52. AnaptysBio's PEG ratio is 0.16.

    PE Ratio

    n/a
    		 -2.59

    Forward PE

    n/a
    		 -4.52

    PS Ratio

    n/a
    		 4.12

    Forward PS

    n/a
    		 4.1

    PB Ratio

    n/a
    		 5.3

    P/FCF Ratio

    n/a
    		 -2.77

    PEG Ratio

    n/a
    		 0.16
    Financial Ratio History

    Enterprise Valuation

    Currently the Enterprise Value (EV) is not available for AnaptysBio.

    EV / Sales

    n/a
    		 n/a

    EV / EBITDA

    n/a
    		 n/a

    EV / EBIT

    n/a
    		 n/a

    EV / FCF

    n/a
    		 n/a

    Financial Position

    The company has a current ratio of 9.51, with a Debt / Equity ratio of 0.23.

    Current Ratio

    n/a
    		 9.51

    Quick Ratio

    n/a
    		 9.51

    Debt / Equity

    n/a
    		 0.23

    Debt / EBITDA

    n/a
    		 -0.17

    Debt / FCF

    n/a
    		 -0.12

    Interest Coverage

    n/a
    		 -2.29

    Financial Efficiency

    Return on Equity is n/a and Return on Invested Capital is n/a.

    Return on Equity

    n/a
    		 n/a

    Return on Assets

    n/a
    		 n/a

    Return on Invested Capital

    n/a
    		 n/a

    Revenue Per Employee

    n/a
    		 $671,176.47

    Profits Per Employee

    n/a
    		 $-1,067,875

    Employee Count

    n/a
    		 136

    Asset Turnover

    n/a
    		 0.19

    Inventory Turnover

    n/a
    		 n/a

    Taxes

    Income Tax

    n/a
    		 3K

    Effective Tax Rate

    n/a
    		 0%

    Stock Price Statistics

    The stock price has increased by -9.79% in the last 52 weeks. The beta is -0.27, so AnaptysBio's price volatility has been lower than the market average.

    Beta

    n/a
    		 -0.27

    52-Week Price Change

    n/a
    		 -9.79%

    50-Day Moving Average

    n/a
    		 21.65

    200-Day Moving Average

    n/a
    		 21.76

    Relative Strength Index (RSI)

    n/a
    		 47.96

    Average Volume (20 Days)

    n/a
    		 662,054

    Income Statement

    In the last 12 months, AnaptysBio had revenue of 91.28M and earned -145.23M in profits. Earnings per share was -5.12.

    Revenue

    n/a
    		 91.28M

    Gross Profit

    n/a
    		 88.88M

    Operating Income

    n/a
    		 -114.95M

    Net Income

    n/a
    		 -145.23M

    EBITDA

    n/a
    		 -92.74M

    EBIT

    n/a
    		 -95.14M

    Earnings Per Share (EPS)

    n/a
    		 -5.12
    Full Income Statement

    Balance Sheet

    The company has 123.08M in cash and 16.04M in debt, giving a net cash position of 107.04M.

    Cash & Cash Equivalents

    n/a
    		 123.08M

    Total Debt

    n/a
    		 16.04M

    Net Cash

    n/a
    		 107.04M

    Retained Earnings

    n/a
    		 -759.33M

    Total Assets

    n/a
    		 422.05M

    Working Capital

    n/a
    		 319.07M
    Full Balance Sheet

    Cash Flow

    In the last 12 months, operating cash flow was -135.34M and capital expenditures -358K, giving a free cash flow of -135.69M.

    Operating Cash Flow

    n/a
    		 -135.34M

    Capital Expenditures

    n/a
    		 -358K

    Free Cash Flow

    n/a
    		 -135.69M

    FCF Per Share

    n/a
    		 -4.78
    Full Cash Flow Statement

    Margins

    Gross margin is 97.37%, with operating and profit margins of -125.93% and -159.1%.

    Gross Margin

    n/a
    		 97.37%

    Operating Margin

    n/a
    		 -125.93%

    Pretax Margin

    n/a
    		 -159.1%

    Profit Margin

    n/a
    		 -159.1%

    EBITDA Margin

    n/a
    		 -101.6%

    EBIT Margin

    n/a
    		 -125.93%

    FCF Margin

    n/a
    		 -148.66%

    Dividends & Yields

    ANAB does not appear to pay any dividends at this time.

    Dividend Per Share

    n/a
    		 n/a

    Dividend Yield

    n/a
    		 n/a

    Dividend Growth (YoY)

    n/a
    		 n/a

    Payout Ratio

    n/a
    		 n/a

    Earnings Yield

    n/a
    		 n/a

    FCF Yield

    n/a
    		 n/a
    Dividend Details

    Analyst Forecast

    The average price target for ANAB is $39, which is 75.7% higher than the current price. The consensus rating is "Buy".

    Price Target

    n/a
    		 $39

    Price Target Difference

    n/a
    		 75.7%

    Analyst Consensus

    n/a
    		 Buy

    Analyst Count

    n/a
    		 9
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 n/a

    Lynch Upside

    n/a
    		 n/a

    Graham Number

    n/a
    		 n/a

    Graham Upside

    n/a
    		 n/a

    Scores

    Altman Z-Score

    n/a
    		 -1.2

    Piotroski F-Score

    n/a
    		 4

    Add to Watchlist